MedTrace Logo

Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

NCT06965816 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2025-05-11

No results posted yet for this study

Summary

This study aims to better understand Alzheimer's disease by looking at brain scans, specifically MRI images, to detect early signs of brain changes linked to the disease. Researchers are focusing on the hippocampus, a part of the brain that shrinks in people with Alzheimer's. The study will also explore other brain changes that often happen alongside hippocampal shrinkage. By analyzing these brain images, the study hopes to find ways to diagnose Alzheimer's earlier and more accurately using advanced imaging techniques.

Conditions

  • Alzheimer's Disease
  • Hippocampus
  • Brain Atrophy
  • Magnetic Resonance Imaging
  • Leukoaraiosis
  • Neurodegenerative Diseases
  • Cortical and Subcortical Atrophy

Sponsors & Collaborators

  • Centre Hospitalier de Saint-Denis

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-24
Primary Completion
2023-05-24
Completion
2023-05-24

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06965816 on ClinicalTrials.gov